InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
IIN | IIN | 13/02/16 | 19 | 7.5K | |||
|
|||||||
IIN | Ann: Ceasing to be a substantial holder | 11/09/15 | 0 | 714 | |||
|
|||||||
IIN | Ann: Implementation of iiNet Scheme of Arrangement | 11/09/15 | 8 | 3.3K | |||
|
|||||||
IIN | Ann: Ceasing to be a substantial holder from MS | 11/09/15 | 0 | 349 | |||
|
|||||||
IIN | Ann: Removal from Official List 11 September 2015 | 10/09/15 | 0 | 561 | |||
|
|||||||
IIN | Ann: Final Director's Interest Notice | 25/08/15 | 0 | 471 | |||
|
|||||||
IIN | Ann: Final Director's Interest Notice | 25/08/15 | 0 | 395 | |||
|
|||||||
IIN | Ann: Final Director's Interest Notice | 25/08/15 | 0 | 393 | |||
|
See All Discussions